Health

Results: 5521-5532 of 6042

PR Newswire associated0

NFP Acquires SeaChange Limited, a Health and Safety Consultancy

PR Newswire associated0

New 'One World, One Health' Report Shows Critical Need for Closer Collaboration Between Key Stakeholders Across Human, Animal, and Environmental Health

PR Newswire associated0

Alkermes Announces Effectiveness of Mural Oncology Form 10 Registration Statement

From left to right: Altasciences' Dr. Lynne Le Sauteur, Dr. Susan Ohorodnik, Ian Vanterpool, and Michael Qualls at the bioanalytical laboratory opening in Columbia, Missouri (Photo: Business Wire)

Altasciences Completes Expansion of New State-Of-The-Art Laboratory in Columbia, Missouri

Eighth Place for the Class40 IBSA in the Furious Stage Le Havre-Lorient

PR Newswire associated0

ALLOSOURCE ANNOUNCES FIRST PATIENT IMPLANTATION IN UNITED KINGDOM CLINICAL EVALUATION OF PROCHONDRIX CR CRYOPRESERVED OSTEOCHONDRAL ALLOGRAFT

Evaxion Announces Encouraging Initial Phase 2 Clinical Data on Its Personalized Cancer Vaccine EVX-01

Human Biome Announces Prediction of first-in class, Biosynthetic Microbiome Against Silent Pandemic of Antibiotic-Resistant Bacteria and Doses First Patients in Contextual FMT Study to validate it

BerGenBio Announces Poster Presentation at Upcoming SITC Meeting

RMK Launches Color Blind Glasses ‘Dalton’

PR Newswire associated0

BioLineRx entered Exclusive License Agreement to Motixafortide in Asia, advisored by M.S.Q. Ventures

PR Newswire associated0

U.S. FDA AWARDS BOTH RARE PEDIATRIC DISEASE AND ORPHAN DRUG DESIGNATIONS TO HG204, A CRISPR RNA-EDITING THERAPY, FOR THE TREATMENT OF MECP2 DUPLICATION SYNDROME